AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Connor, L.
Right arrow Articles by Mason, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Connor, L.
Right arrow Articles by Mason, K. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2003; 181:1691-1694
© American Roentgen Ray Society


Effects of IV Pentobarbital With and Without Fentanyl on End-Tidal Carbon Dioxide Levels During Deep Sedation of Pediatric Patients Undergoing MRI

Linda Connor1, Patricia E. Burrows1, David Zurakowski2, Kathleen Bucci1, Denise A. Gagnon1 and Keira P. Mason1,3

1 Department of Radiology, Children's Hospital, 300 Longwood Ave., Harvard Medical School, Boston, MA 02115.
2 Departments of Biostatistics and Orthopaedic Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115.
3 Department of Anesthesia, Children's Hospital, Harvard Medical School, Boston, MA 02115.

OBJECTIVE. IV pentobarbital is used in radiology departments for sedating pediatric patients undergoing diagnostic imaging. To our knowledge, no published studies have documented end-tidal carbon dioxide levels during sedation with IV pentobarbital. The purpose of this prospective study was to determine the effects of different doses of IV pentobarbital with or without fentanyl on end-tidal carbon dioxide levels during deep sedation of pediatric patients undergoing MRI.

SUBJECTS AND METHODS. One hundred sixty-five patients (70 girls, 95 boys) having a mean age of 3.4 years received IV pentobarbital sedation with or without fentanyl for undergoing MRI from January through March 2002. Each child was sedated with 2–6 mg/kg of body weight of IV pentobarbital and an additional 1–3 µg/kg of fentanyl if needed. After the administration of sedation, a 28-ft (8.5 m) nasal cannula with capnography capability was applied to each patient, and capnogram tracings and values were recorded every 5 min.

RESULTS. Mean values of end-tidal carbon dioxide were between 37 and 42 mm Hg during 60 min of sedation for both groups. When IV pentobarbital was used alone, no significant difference was seen between patients who received 3–5 mg of pentobarbital and those who received more than 5 mg (p = 0.97, F test).

CONCLUSION. End-tidal carbon dioxide levels remain within normal clinical range during sedation with IV pentobarbital with or without fentanyl. Our sedation protocol produced no significant deviations from normal respiratory parameters.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
J. Pershad, J. Wan, and D. L. Anghelescu
Comparison of Propofol With Pentobarbital/Midazolam/Fentanyl Sedation for Magnetic Resonance Imaging of the Brain in Children
Pediatrics, September 1, 2007; 120(3): e629 - e636.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. J. Dalens, A. M. Pinard, D.-R. Letourneau, N. T. Albert, and R. J. Y. Truchon
Prevention of emergence agitation after sevoflurane anesthesia for pediatric cerebral magnetic resonance imaging by small doses of ketamine or nalbuphine administered just before discontinuing anesthesia.
Anesth. Analg., April 1, 2006; 102(4): 1056 - 1061.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.